ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Scientist II at CRISPR Therapeutics - ApplyBlast

Scientist II

CRISPR Therapeutics

1 month ago

3.1 on Glassdoor

South Boston, Massachusetts, United States

Onsite

Full Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

CRISPR Therapeutics is seeking a Scientist II to join its CRISPR-X team, focusing on the research and development of next-generation gene editing therapies and synthetic immunology. The role involves designing and executing advanced molecular biology experiments, including CRISPR-based gene insertions and CAR T cell engineering, to advance novel genetic treatments for human diseases. This position requires a strong background in gene editing technologies and immune cell biology to drive translational research and innovation.

Responsibilities

Lead and optimize next-generation gene editing strategies using CRISPR-based tools
Design and execute molecular biology research including cloning and cell-based assays
Guide construct design and interpret phenotypic outcomes of in-vivo CAR T studies

Skills

Qualifications

Ph.D. in biology, bioengineering, immunology, or related discipline

About CRISPR Therapeutics

crisprtx.com

Headquarters

Boston, Massachusetts, United States

Company Size

201-500 employees

Founded

2013

View Profile

CRISPR Therapeutics is a gene-editing company pioneering the development of transformative medicines using CRISPR/Cas9 technology to treat serious diseases. The company has a broad pipeline spanning hemoglobinopathies, immuno-oncology, autoimmune diseases, in vivo editing, and regenerative medicine, including CASGEVY™, the first-ever approved CRISPR-based therapy for sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics operates across multiple clinical and preclinical programs in collaboration with partners such as Vertex Pharmaceuticals.